184 related articles for article (PubMed ID: 32044955)
1. Conditional Survival, Cause-Specific Mortality, and Risk Factors of Late Mortality After Allogeneic Hematopoietic Cell Transplantation.
Wong FL; Teh JB; Atencio L; Stiller T; Kim H; Chanson D; Forman SJ; Nakamura R; Armenian SH
J Natl Cancer Inst; 2020 Nov; 112(11):1153-1161. PubMed ID: 32044955
[TBL] [Abstract][Full Text] [Related]
2. Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.
Atsuta Y; Hirakawa A; Nakasone H; Kurosawa S; Oshima K; Sakai R; Ohashi K; Takahashi S; Mori T; Ozawa Y; Fukuda T; Kanamori H; Morishima Y; Kato K; Yabe H; Sakamaki H; Taniguchi S; Yamashita T;
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1702-1709. PubMed ID: 27246369
[TBL] [Abstract][Full Text] [Related]
3. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.
Bhatia S; Francisco L; Carter A; Sun CL; Baker KS; Gurney JG; McGlave PB; Nademanee A; O'Donnell M; Ramsay NK; Robison LL; Snyder D; Stein A; Forman SJ; Weisdorf DJ
Blood; 2007 Nov; 110(10):3784-92. PubMed ID: 17671231
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.
Wingard JR; Majhail NS; Brazauskas R; Wang Z; Sobocinski KA; Jacobsohn D; Sorror ML; Horowitz MM; Bolwell B; Rizzo JD; Socié G
J Clin Oncol; 2011 Jun; 29(16):2230-9. PubMed ID: 21464398
[TBL] [Abstract][Full Text] [Related]
5. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.
Keller JW; Andreadis C; Damon LE; Kaplan LD; Martin TG; Wolf JL; Ai WZ; Venstrom JM; Smith CC; Gaensler KM; Hwang J; Olin RL
J Geriatr Oncol; 2014 Jul; 5(3):238-44. PubMed ID: 24894413
[TBL] [Abstract][Full Text] [Related]
7. Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients.
Solh MM; Bashey A; Solomon SR; Morris LE; Zhang X; Brown S; Holland HK
Bone Marrow Transplant; 2018 May; 53(5):576-583. PubMed ID: 29335633
[TBL] [Abstract][Full Text] [Related]
8. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.
Goldman JM; Majhail NS; Klein JP; Wang Z; Sobocinski KA; Arora M; Horowitz MM; Rizzo JD
J Clin Oncol; 2010 Apr; 28(11):1888-95. PubMed ID: 20212247
[TBL] [Abstract][Full Text] [Related]
9. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
Fulcher J; Blanchard AP; Bredeson C; van Walraven C
Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.
de la Morena MT; Leonard D; Torgerson TR; Cabral-Marques O; Slatter M; Aghamohammadi A; Chandra S; Murguia-Favela L; Bonilla FA; Kanariou M; Damrongwatanasuk R; Kuo CY; Dvorak CC; Meyts I; Chen K; Kobrynski L; Kapoor N; Richter D; DiGiovanni D; Dhalla F; Farmaki E; Speckmann C; Español T; Shcherbina A; Hanson IC; Litzman J; Routes JM; Wong M; Fuleihan R; Seneviratne SL; Small TN; Janda A; Bezrodnik L; Seger R; Raccio AG; Edgar JD; Chou J; Abbott JK; van Montfrans J; González-Granado LI; Bunin N; Kutukculer N; Gray P; Seminario G; Pasic S; Aquino V; Wysocki C; Abolhassani H; Dorsey M; Cunningham-Rundles C; Knutsen AP; Sleasman J; Costa Carvalho BT; Condino-Neto A; Grunebaum E; Chapel H; Ochs HD; Filipovich A; Cowan M; Gennery A; Cant A; Notarangelo LD; Roifman CM
J Allergy Clin Immunol; 2017 Apr; 139(4):1282-1292. PubMed ID: 27697500
[TBL] [Abstract][Full Text] [Related]
11. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.
Bhatia S; Robison LL; Francisco L; Carter A; Liu Y; Grant M; Baker KS; Fung H; Gurney JG; McGlave PB; Nademanee A; Ramsay NK; Stein A; Weisdorf DJ; Forman SJ
Blood; 2005 Jun; 105(11):4215-22. PubMed ID: 15701723
[TBL] [Abstract][Full Text] [Related]
12. High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation.
Miyamura K; Yamashita T; Atsuta Y; Ichinohe T; Kato K; Uchida N; Fukuda T; Ohashi K; Ogawa H; Eto T; Inoue M; Takahashi S; Mori T; Kanamori H; Yabe H; Hama A; Okamoto S; Inamoto Y
Blood Adv; 2019 Feb; 3(3):397-405. PubMed ID: 30728138
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.
Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Wadhwa A; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Armenian SH; Arora M; Bhatia S
JAMA Oncol; 2018 Dec; 4(12):e182453. PubMed ID: 30054602
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.
Patel SS; Rybicki LA; Corrigan D; Bolwell B; Dean R; Liu H; Gerds AT; Hanna R; Hill B; Jagadeesh D; Kalaycio M; Pohlman B; Sobecks R; Majhail NS; Hamilton BK
Biol Blood Marrow Transplant; 2018 May; 24(5):1029-1034. PubMed ID: 29369800
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Myers RM; Hill BT; Shaw BE; Kim S; Millard HR; Battiwalla M; Majhail NS; Buchbinder D; Lazarus HM; Savani BN; Flowers MED; D'Souza A; Ehrhardt MJ; Langston A; Yared JA; Hayashi RJ; Daly A; Olsson RF; Inamoto Y; Malone AK; DeFilipp Z; Margossian SP; Warwick AB; Jaglowski S; Beitinjaneh A; Fung H; Kasow KA; Marks DI; Reynolds J; Stockerl-Goldstein K; Wirk B; Wood WA; Hamadani M; Satwani P
Cancer; 2018 Feb; 124(4):816-825. PubMed ID: 29125192
[TBL] [Abstract][Full Text] [Related]
17. Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease.
Vaughn JE; Gooley T; Maziarz RT; Pulsipher MA; Bhatia S; Maloney DG; Sandmaier BM; Flowers ME; Storb R; Sorror ML
Br J Haematol; 2015 Nov; 171(3):411-6. PubMed ID: 26194447
[TBL] [Abstract][Full Text] [Related]
18. Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34
Scordo M; Shah GL; Kosuri S; Herrera DA; Cho C; Devlin SM; Maloy MA; Nieves J; Borrill T; Avecilla ST; Meagher RC; Carlow DC; O'Reilly RJ; Papadopoulos EB; Jakubowski AA; Koehne G; Gyurkocza B; Castro-Malaspina H; Tamari R; Perales MA; Giralt SA; Shaffer BC
Biol Blood Marrow Transplant; 2018 Jan; 24(1):133-141. PubMed ID: 28870777
[TBL] [Abstract][Full Text] [Related]
19. Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.
Vrooman LM; Millard HR; Brazauskas R; Majhail NS; Battiwalla M; Flowers ME; Savani BN; Akpek G; Aljurf M; Bajwa R; Baker KS; Beitinjaneh A; Bitan M; Buchbinder D; Chow E; Dandoy C; Dietz AC; Diller L; Gale RP; Hashmi SK; Hayashi RJ; Hematti P; Kamble RT; Kasow KA; Kletzel M; Lazarus HM; Malone AK; Marks DI; O'Brien TA; Olsson RF; Ringden O; Seo S; Steinberg A; Yu LC; Warwick A; Shaw B; Duncan C
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1327-1334. PubMed ID: 28461213
[TBL] [Abstract][Full Text] [Related]
20. Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.
Chow EJ; Cushing-Haugen KL; Cheng GS; Boeckh M; Khera N; Lee SJ; Leisenring WM; Martin PJ; Mueller BA; Schwartz SM; Baker KS
J Clin Oncol; 2017 Jan; 35(3):306-313. PubMed ID: 27870568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
